<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To establish the prevalence of inflammatory secretory phospholipase A2 (sPLA2) and cytoplasmic phospholipase A2 (cPLA2) expression in a surgical series of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and associated <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> and to correlate this expression with clinicopathological data and prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: sPLA2 and cPLA2 were analysed by means of immunohistochemistry in surgical specimens of 67 and 73 cases of Barrett's <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Barrett's mucosa was analysed in 31 cases </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Expression of sPLA2 was detected in 48% of Barrett's mucosa negative for intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and 63% of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Semi-quantitative analysis revealed a significant increase in sPLA2 expression between Barrett's mucosa negative for intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>cPLA2 expression was detected in 18% of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>An inverse correlation was found between cPLA2 expression and depth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> infiltration, neoplastic vascular invasion and neoplastic perineural invasion </plain></SENT>
<SENT sid="7" pm="."><plain>Survival analysis showed no significant prognostic value for sPLA2 and cPLA2 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: sPLA2 is frequently expressed in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The increasing expression of sPLA2 that we observed from Barrett's mucosa to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> suggests that sPLA2 could be involved in Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, cPLA2 expression is less frequently observed in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and is inversely associated with aggressive pathological features of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
</text></document>